Lexicon Pharmaceuticals is reverting to a clinical development company after facing repeated setbacks at the FDA for its type 1 diabetes and chronic kidney disease drug.
Eli Lilly has appointed Procter & Gamble CEO Jon Moeller to the board of directors, while Goldman Sachs operating partner Karen Walker will resign from ...
A female Rett syndrome patient died Wednesday after receiving Neurogene’s gene therapy in a clinical trial, the company disclosed in a new ...